Skip to content

Three Loeb Partners Recognized in the LMG Life Sciences 2025 Rankings

Loeb & Loeb is pleased to share that Mitchell Nussbaum, co-chair of Loeb & Loeb; Jim Czaban, co-chair of the Life Sciences industry group; and Capital Markets & Corporate partner Norwood Beveridge were named in the 2025 edition of the LMG Life Sciences rankings, a definitive guide to lawyers and law firms that specialize in the life sciences industry.

The rankings highlight firms and lawyers that specialize in four main practice areas: regulatory, intellectual property, financial and corporate, and non-IP litigation and enforcement. Mitch and Norwood were recognized in the Corporate category, whereas Jim was recognized in the FDA: Medical Device and FDA: Pharmaceutical categories.

LMG Life Sciences is the only legal ranking directory to identify the leading law firms and individuals in each practice area of the life sciences sector through deep analysis of the business and legal developments in the sector. The intricacies of life science products require a diverse array of legal expertise across many disciplines. From regulatory approval or patent filing to collaborative transactions or product liabilities, legal practitioners play an important role in guiding a product through its life cycle. The guide recognizes that products born from biotechnology, pharmaceutical, medical device and agritech companies also demand a sophisticated scientific understanding. 

For more information, please visit LMG Life Sciences’ website.